Delivery Order SPE2DB22D1106-SPE2DB24FFLN9
Award Date
9/7/24
Potential Completion Date
9/9/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm fixed-price delivery order, valued at $2,243.89, has an ultimate completion date of September 19, 2024. The award was made on September 18, 2024 and does not have a set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The $1,414.56 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,929.78, is a firm fixed price delivery order for the pharmaceutical product CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award is a delivery order valued at $1,378.38 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a completion date of February 16, 2024. The contract is a firm fixed price award with no set-aside designation....
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of a pharmaceutical product, CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract has a firm fixed price of $6,213.04 and a completion date of April 25, 2024. The contract is a delivery order, which is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,022.24 firm-fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to various government agencies and healthcare programs....
This federal contract award, valued at $1,161.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. It is not designated as a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,125.77 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a Delivery Order valued at $1,747.86 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 14, 2024. The contract is a Firm Fixed Price type with no set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen frequently receives federal contract awards from the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.40 Firm Fixed Price delivery order contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has a period of performance through May 14, 2025 and is not set aside for any socioeconomic category. Amerisourcebergen holds a substantial Indefinite Delivery Contract...